SOURCE: World Street Fundamentals

October 27, 2011 09:00 ET

Analyst View, Impact of Global Events - Research Report on SXC Health Solutions Corp. (USA) and InterMune, Inc.

HONG KONG--(Marketwire - Oct 27, 2011) - Today, released its industry report highlighting SXC Health Solutions Corp. (USA) (NASDAQ: SXCI) and InterMune, Inc. (NASDAQ: ITMN). Full fundamental and technical analysis is available at

Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. "Significant downside risks" to the US economy were confirmed by the Federal Reserve pressured by "strains in global financial markets."

As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis - furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.

Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.

World Street Fundamentals has highlighted SXC Health Solutions Corp. (USA) for its current position within the technology industry. SXC Health Solutions Corp. (SXC) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions. Its customers include pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party health care plan administrators, and state and federal government entities. The entire report on SXC Health Solutions Corp. (USA) (NASDAQ: SXCI) is available here:

World Street has featured InterMune, Inc. for its development within the healthcare industry. InterMune, Inc. (InterMune) is a biopharmaceutical company focused on developing and commercializing therapies in pulmonology and hepatology. The entire report on InterMune, Inc. (NASDAQ: ITMN) is available here:

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.

Contact Information